June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Verteporfin Inhibits YAP Activation in Trabecular Meshwork Cells without Light Stimulation: Implication for Glaucoma Treatment
Author Affiliations & Notes
  • Wei-Sheng Chen
    Ophthalmology, Tufts University, Boston, MA
  • Zhiyi Cao
    Ophthalmology, Tufts University, Boston, MA
  • Noorjahan A Panjwani
    Ophthalmology, Tufts University, Boston, MA
  • Footnotes
    Commercial Relationships Wei-Sheng Chen, None; Zhiyi Cao, None; Noorjahan Panjwani, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3284. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Wei-Sheng Chen, Zhiyi Cao, Noorjahan A Panjwani; Verteporfin Inhibits YAP Activation in Trabecular Meshwork Cells without Light Stimulation: Implication for Glaucoma Treatment. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3284.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Glaucoma affects over 60 million adults worldwide. Verteporfin, a photosensitizer, is used in photodynamic therapy to treat age-related macular degeneration. Published studies have shown that Verteporfin inhibits YAP activation without light stimulation. YAP is a mechanotransducor, and YAP activation in the nucleus through interaction with TEAD has emerged as an important pathway in the pathogenesis of glaucoma. We hypothesize that targeting YAP by Verteporfin may ameliorate glaucoma.

Methods: To assess the effect of Verteporfin on trabecular meshwork (TM) cell-mediated collagen gel contraction, TM cells were embedded in collagen gel in the presence or absence of Verteporfin for 48 hr. Areas of collagen gel sizes were quantified by ImageJ. To determine the effect of Verteporfin on fibronectin-mediated cell spreading, TM cells were pretreated with Verteporfin, detached, and plated on fibronectin-coated wells for 2 hours. Actin filaments were stained with Acti-Stain 555-labeled phalloidin and cell spreading areas were quantified by ImageJ. Gene expression of connective tissue growth factor (CTGF) in TM cells was analyzed by qPCR. Cytotoxic effect of Verteporfin was assessed by WST-1.

Results: We demonstrated here that Verteporfin (i) abolishes TM cell-mediated collagen gel contraction in a dose-dependent manner, (ii) has no significant toxicity below 2 μM, (iii) reduces fibronectin-mediated TM cell adhesion and spreading, (iv) interferes with fibronectin-mediated stress fiber reorganization, and (v) attenuates TGF-β2-induced upregulation of CTGF.

Conclusions: Our results indicate that Verteporfin without light stimulation may reduce intraocular pressure by facilitating aqueous humor outflow through the TM-Schlemm’s canal system.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.